{"id":7560,"date":"2018-10-22T00:00:00","date_gmt":"2018-10-21T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2018\/10\/22\/el-model-idibell-dinnovacio-en-salut-viatja-a-barcelona-i-japo\/"},"modified":"2020-08-07T10:42:29","modified_gmt":"2020-08-07T08:42:29","slug":"el-model-idibell-dinnovacio-en-salut-viatja-a-barcelona-i-japo","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2018\/10\/el-model-idibell-dinnovacio-en-salut-viatja-a-barcelona-i-japo\/","title":{"rendered":"El model IDIBELL d\u2019innovaci\u00f3 en salut viatja a Barcelona i Jap\u00f3\u00a0"},"content":{"rendered":"

L\u2019equip d\u2019innovaci\u00f3 i desenvolupament de negoci de l\u2019IDIBELL ha participat en la segona edici\u00f3 de HEALTHIO<\/a>, un esdeveniment celebrat els passats dies 16, 17 i 18 d\u2019octubre amb l\u2019objectiu d\u2019experimentar i gaudir de les \u00faltimes innovacions en el camp de la salut. Una delegaci\u00f3 liderada per Gisela Lorente, responsable del portafolis d\u2019innovaci\u00f3 de l\u2019IDIBELL, ha donat a con\u00e8ixer les oportunitats de transfer\u00e8ncia de coneixement i desenvolupament de negoci que ofereix l\u2019IDIBELL des d\u2019un estand propi obert a empreses, col\u00b7laboradors potencials i visitants en general.<\/p>\n

Organitzat per Fira de Barcelona, HEALTHIO ha reunit ciutadans, professionals sanitaris i empreses innovadores en un espai obert per impulsar el di\u00e0leg entre tots els agents que integren l’ecosistema sanitari i propiciar l’evoluci\u00f3 del sistema. Els prop de 4.500 visitants de HEALTHIO han pogut con\u00e8ixer les novetats i l’oferta dels 115 expositors a trav\u00e9s de 25 itineraris o visitades guiades i escoltar a m\u00e9s de 321 ponents en 420 xerrades (\u00e0gores) entre els quals s\u2019hi ha incl\u00f2s molts noms vinculats a l\u2019ecosistema de Bellvitge i les spin-off de l\u2019IDIBELL: Gabriel Capell\u00e1, \u00c1ngel Raya, \u00d2scar Mart\u00ednez-Tirado, Oriol Casanovas, Oriol Bestard, Josep Com\u00edn, Fernando Fern\u00e1ndez-Aranda, M\u00f3nica Povedano, N\u00faria Montesinos, Marta Barrachina (ADmit Therapeutics), Rafel M\u00e1\u00f1ez (RemAb Therapeutics), Anna Portela (Xenopat), Joan Gilabert (Tractivus).<\/p>\n

A m\u00e9s a m\u00e9s, durant la segona semana d\u2019octubre, la directora d\u2019innovaci\u00f3 i desenvolupament de negoci de l\u2019IDIBELL, Raquel Egea, ha format part de l\u2019equip de la missi\u00f3 empresarial en el marc de la fira BioJapan<\/a> organitzada per ACCI\u00d3. Aquesta missi\u00f3 es va dur a terme en el marc de la 20ena edici\u00f3 de la fira BioJapan (Yokohama), la fira de refer\u00e8ncia a nivell asi\u00e0tic de la ind\u00fastria biotecnol\u00f2gica mundial i on es donen cita els principals professionals de desenvolupament de negocis i llic\u00e8ncies de la ind\u00fastria biotecnologia d’arreu.<\/p>\n

La fira representa \u201cuna gran oportunitat ja que les empreses japoneses del sector estan en ple proc\u00e9s de globalitzaci\u00f3 i necessiten aliances amb empreses i institucions biotecnol\u00f2giques estrangeres per desenvolupar nous medicaments i incorporar noves tecnol\u00f2gies\u201d, explica Egea. Aquest any, BioJapan ha incl\u00f2s una zona HealthCare (dedicada a gesti\u00f3 de la salut i rehabilitaci\u00f3, entre d\u2019altres \u00e0mbits) i una zona de salut digital, smart cell industry o eHealth, amb les innovacions m\u00e9s modernes del sector de ci\u00e8ncies del a vida i de la salut.<\/p>\n","protected":false},"excerpt":{"rendered":"

L’IDIBELL participa a les fires HEALTHIO i BioJapan<\/p>\n","protected":false},"author":6,"featured_media":7561,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,397,417,359,374,493,339,483,398],"tags":[161],"class_list":["post-7560","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","category-angiogenesi-tumoral","category-cancer-hereditari-noticies","category-malalties-cardiovasculars","category-immunitat-innata-i-patologia-del-malalt-critic","category-innovacio","category-nefrologia-i-transplantament-renal","category-potencia-de-cellules-mare","category-sarcoma","tag-promocio"],"publishpress_future_action":{"enabled":false,"date":"2025-01-29 06:52:08","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7560"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7560\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/7561"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}